{"title":"在肾素-血管紧张素-醛固酮系统基因多态性背景下使用血管紧张素 II 1 型受体拮抗剂治疗慢性心力衰竭","authors":"Izmozherova N.V. Izmozherova, Grenaderova M.A. Grenaderova, Shambatov M.A. Shambatov, Popov A.A. Popov, Kudryavtseva E.V. Kudryavtseva, Bortnik A.E. Bortnik, Vishneva K.A. Vishneva, Shamilov M.D. Shamilov","doi":"10.18565/pharmateca.2024.1.70-77","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":20153,"journal":{"name":"Pharmateca","volume":" 45","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The use of angiotensin II type 1 receptor antagonists in the treatment of chronic heart failure against the background of the renin-angiotensin-aldosterone system genetic polymorphisms\",\"authors\":\"Izmozherova N.V. Izmozherova, Grenaderova M.A. Grenaderova, Shambatov M.A. Shambatov, Popov A.A. Popov, Kudryavtseva E.V. Kudryavtseva, Bortnik A.E. Bortnik, Vishneva K.A. Vishneva, Shamilov M.D. Shamilov\",\"doi\":\"10.18565/pharmateca.2024.1.70-77\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":20153,\"journal\":{\"name\":\"Pharmateca\",\"volume\":\" 45\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmateca\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18565/pharmateca.2024.1.70-77\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmateca","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18565/pharmateca.2024.1.70-77","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The use of angiotensin II type 1 receptor antagonists in the treatment of chronic heart failure against the background of the renin-angiotensin-aldosterone system genetic polymorphisms